These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16278416)

  • 1. Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models.
    Huizen IV; Wu G; Moussa M; Chin JL; Fenster A; Lacefield JC; Sakai H; Greenberg NM; Xuan JW
    Clin Cancer Res; 2005 Nov; 11(21):7911-9. PubMed ID: 16278416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
    Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.
    Nam RK; Reeves JR; Toi A; Dulude H; Trachtenberg J; Emami M; Daigneault L; Panchal C; Sugar L; Jewett MA; Narod SA
    J Urol; 2006 Apr; 175(4):1291-7. PubMed ID: 16515983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse PSP94 expression is prostate tissue-specific as demonstrated by a comparison of multiple antibodies against recombinant proteins.
    Thota A; Karajgikar M; Duan W; Gabril MY; Chan FL; Wong YC; Sakai H; Chin JL; Moussa M; Xuan JW
    J Cell Biochem; 2003 Apr; 88(5):999-1011. PubMed ID: 12616537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.
    Imasato Y; Xuan JW; Sakai H; Izawa JI; Saito Y; Chin JL; Moussa M
    J Urol; 2000 Nov; 164(5):1819-24. PubMed ID: 11025776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model.
    Duan W; Gabril MY; Moussa M; Chan FL; Sakai H; Fong G; Xuan JW
    Oncogene; 2005 Feb; 24(9):1510-24. PubMed ID: 15674347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy.
    Reeves JR; Dulude H; Panchal C; Daigneault L; Ramnani DM
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6018-22. PubMed ID: 17062675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients.
    Yashi M; Muraishi O; Kobayashi Y; Tokue A; Nanjo H
    Prostate; 2002 May; 51(2):84-97. PubMed ID: 11948963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (I). Immuno-dominant and immuno-recessive area.
    Xuan JW; Wu D; Guo Y; Garde S; Baijal-Gupta M; Chin JL
    J Cell Biochem; 1997 May; 65(2):172-85. PubMed ID: 9136076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (II). Epitope mapping by monoclonal antibodies.
    Xuan JW; Wu D; Guo Y; Huang CL; Wright GL; Chin JL
    J Cell Biochem; 1997 May; 65(2):186-97. PubMed ID: 9136077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies.
    Gabril MY; Duan W; Wu G; Moussa M; Izawa JI; Panchal CJ; Sakai H; Xuan JW
    Mol Ther; 2005 Mar; 11(3):348-62. PubMed ID: 15727931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice.
    Lyons SK; Lim E; Clermont AO; Dusich J; Zhu L; Campbell KD; Coffee RJ; Grass DS; Hunter J; Purchio T; Jenkins D
    Cancer Res; 2006 May; 66(9):4701-7. PubMed ID: 16651422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
    Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer.
    Meyer-Siegler KL; Iczkowski KA; Vera PL
    BMC Cancer; 2005 Jul; 5():73. PubMed ID: 16000172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of PSP94 in rat prostate lobes as demonstrated by an antibody against recombinant GST-PSP94.
    Kwong J; Chan FL; Jiang S; Guo Y; Imasato Y; Sakai H; Koropatnick J; Chin JL; Xuan JW
    J Cell Biochem; 1999 Sep; 74(3):406-17. PubMed ID: 10412042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.
    Gross M; Top I; Laux I; Katz J; Curran J; Tindell C; Agus D
    Clin Cancer Res; 2007 Apr; 13(7):1979-86. PubMed ID: 17404077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
    Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
    Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
    Kasper S
    J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of initiation of angiogenesis in early stages of prostate adenocarcinoma development and progression in a transgenic murine model.
    Gabril M; Xuan J; Moussa M; Dinney CP; Chin JL; Izawa JI
    Urology; 2004 Dec; 64(6):1233-7. PubMed ID: 15596214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.